Hemafer (Iron)

Hemafer is used to address iron deficiency and its clinical consequences.

• Treatment of iron deficiency anemia in adults and adolescents.
• Prevention of iron deficiency in individuals with increased physiological needs, such as during growth, menstruation, or pregnancy.
• Support for people following vegetarian or vegan diets who may have limited dietary iron intake.
• Adjunct therapy for patients experiencing chronic blood loss, for example after surgery or gastrointestinal bleeding.
• Supplementation in individuals with malabsorption syndromes that affect iron uptake.

Oral iron supplementation can be associated with a range of side effects, most of which are mild and transient.

Common

• Gastrointestinal discomfort such as nausea, abdominal cramping, or bloating.
• Constipation or, less frequently, loose stools.
• Darkening of the stool color, which is harmless.
• Metallic taste in the mouth.

Serious

• Severe allergic reaction manifesting as rash, itching, swelling, or difficulty breathing.
• Signs of iron overload such as persistent vomiting, abdominal pain, or joint pain.
• Unexplained fatigue or weakness that does not improve with therapy.

Before starting Hemafer, certain precautions should be considered to ensure safe and effective use.

• Verify iron deficiency through appropriate laboratory testing before supplementation.
• Use caution in individuals with known hypersensitivity to iron preparations.
• Avoid use in patients with hereditary hemochromatosis or other iron‑overload disorders.
• Monitor for gastrointestinal side effects and adjust dosage or formulation if needed.
• Discuss use with a healthcare professional during pregnancy, lactation, or when planning pregnancy.
• Consider potential interactions with other medications and supplements.
• Keep out of reach of children to prevent accidental ingestion.

Iron can affect the absorption and efficacy of several other medicines and nutrients.

Avoid

• Concurrent use with tetracycline or quinolone antibiotics, which may reduce the effectiveness of either agent.
• Simultaneous intake with calcium‑containing antacids or supplements, as calcium interferes with iron absorption.

Use with caution

• Levothyroxine therapy, as iron may diminish its absorption; separate dosing by at least 4 hours.
• Bisphosphonates for osteoporosis, which should be taken at a different time to avoid reduced absorption.
• Certain multivitamins or mineral supplements containing zinc or copper, which may compete for absorption pathways.